Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
12/2000
12/26/2000US6166024 Via formulations adapted for delayed-release oral or rectal administration
12/26/2000US6166023 1,5- and 3-O-substituted 1H-indazoles having anti-asthmatic, anti-allergic, anti-inflammatory, immunomodulating and neuroprotective action, process for their preparation and their use as medicaments
12/26/2000US6165993 DNA vaccines against rotavirus infections
12/26/2000US6165988 Copolymerizing an acrylic acid or methacrylic acid ester having a protected aminoalkyl group and a second acrylic acid or methacrylic acid or ester, removing the protecting group, binding the copolymer to an active substance by ionic bond
12/26/2000US6165987 A veterinary parasciticide dose containing a praziquantel, at least one macrolide anthelmintic selected from avermectins and milbemycins and a solvent selected from glycerol formal, ethyl lactate, benzyl alcohol and n-metyl-2-pyrrollidone
12/26/2000US6165983 Use of collagen for the treatment of degenerative articular processes
12/26/2000US6165979 Glutathion disulfide which is an oxidized glutathion when administered parenteral induces the endogenous cytokine and/or hematopoietic factor; used for neoplastic, infectious, hematologic, immunologic or other diseases
12/26/2000US6165615 Gradual-releasing capsule and method for manufacturing the same
12/26/2000US6165516 Mixing a quantity of caffeine with an encapsulating agent to form a physically-modified caffeine having an increased release rate, adding the modified caffeine to a chewing gum formulation to provide a desirable caffeine level in the gum
12/26/2000US6165514 Group iiia element-containing compounds mimic the beneficial biological effects of transforming growth factor beta without side effect, therefore applied directly to the bandage or dressing for wound healing
12/26/2000US6165513 Film-coated tablet for improved upper gastrointestinal tract safety
12/26/2000US6165512 Coating the liquiflash particles with a cellulosic taste-making material, blending the coated particle with glycerine-free bodies, and shaping the blend to produce dosage form
12/26/2000US6165511 Polyol composition
12/26/2000US6165509 Pegylated drug complexed with bioadhesive polymer suitable for drug delivery and methods relating thereto
12/26/2000US6165508 Controlled release of metal cation-stabilized interferon
12/26/2000US6165507 Slow-release pharmaceutical formulations containing mizolastine
12/26/2000US6165506 A solid dose nanoparticulate naproxen formulation having a high rate of dissolution comprising a naproxen having specific particle size, polyvinylpyrrolidone adsorbed on the surface and an alkali agent to increase the dissolution rate
12/26/2000US6165503 Preparing gelled beads of a polyanionic polysaccharide which are cross-linked with a polyvalent cation, forming capsules having polycationic-polyanion membrane of polycationic polysaccharide on gelled beads, culturing the product capsule
12/26/2000US6165502 Protein-lipid vesicles and autogenous vaccine comprising the same
12/26/2000US6165501 Radiation-protective phospholipid and method
12/26/2000US6165500 Preparation for the application of agents in mini-droplets
12/26/2000US6165499 Transdermal therapeutic system with small application-area thickness and great flexibility, and production process
12/26/2000US6165498 Selecting an acrylate polymeric matrix and loratidine metabolite with antihistaminic activity for transdermal patch
12/26/2000US6165497 Subsaturated nicotine transdermal therapeutic system
12/26/2000US6165496 A sheet formed of cross-linked keratin not requiring a binding agent, bound together by reformed disulfide linkage and hydrogen bond, used as wound healing dressing, preferred use is as tissue engineering cell scaffold for grafting
12/26/2000US6165495 A fluid drug is injected through a passageway into the cavity surrounded by and contained within dissolvable shell, the cavity is filled with a fluid drug and passageway is sealed with a elongated member; allows easy administration to child
12/26/2000US6165494 Iodine-containing nasal moisturizing saline and mouthwash solutions
12/26/2000US6165493 "Methods and compositions for decreasing the frequency of HIV, herpesvirus and sexually transmitted bacterial infections"
12/26/2000US6165492 Intrauterine chemical necrosing method, composition, and apparatus
12/26/2000US6165491 Pharmaceutical composition based on estrogen and progesterone
12/26/2000US6165482 Porous clay or charcoal insoluble absorbent in which the pores of the insoluble absorbent are clogged by a coating material selected from the group consisting of isopropyl myristate and dimethylpolysiloxane
12/26/2000US6165481 Highly pure squalane, raw material for pharmaceuticals and cosmetics prepared by using the same and method for producing the same
12/26/2000US6165463 Dispersible antibody compositions and methods for their preparation and use
12/26/2000US6165458 Composition and method for dermal and transdermal administration of a cytokine
12/26/2000US6165445 Pharmaceutical compositions containing alkylaryl polyether alcohol polymer
12/26/2000US6165225 Retrievable bioartificial implants having dimensions allowing rapid diffusion of oxygen and rapid biological response to physiological change, processes for their manufacture, and methods for their use
12/26/2000CA2312512A1 Directly compressible starch as enhancer of properties of excipients when used as binder and disintegrant for compression tablets
12/26/2000CA2120359C Particles, method of preparing said particles and uses thereof
12/26/2000CA2044878C Thermally reversible and irreversible gels
12/22/2000CA2291542A1 Novel composition
12/21/2000WO2000077281A1 Encapsulation of crystals via multilayer coatings
12/21/2000WO2000077227A1 Fibrin sealant as a transfection/transformation vehicle for gene therapy
12/21/2000WO2000077188A2 Dna pcv vaccine
12/21/2000WO2000076555A1 Gel composition for filing a breast milk duct prior to surgical excision of the duct or other breast tissue
12/21/2000WO2000076549A1 Liquid pharmaceutical composition for oral administration of bitter hydrolysis-susceptible active substances
12/21/2000WO2000076548A1 Filler binder for tablets
12/21/2000WO2000076545A1 Anaesthetic formulation comprising an nmda-antagonist and an alpha-2 adrenergic agonist
12/21/2000WO2000076543A1 Ocular tension lowering composition for topical adminstration
12/21/2000WO2000076533A1 Hemoactive compositions and methods for their manufacture and use
12/21/2000WO2000076525A1 Anticancer emulsions containing anthracycline compounds
12/21/2000WO2000076520A1 Antifungal oral composition containing itraconazole and process for preparing same
12/21/2000WO2000076519A1 Sulfonamide and sulfamide substituted imidazoquinolines
12/21/2000WO2000076509A1 Nasal delivery of apomorphine
12/21/2000WO2000076507A1 Method for increasing the solubility of morphine and pharmaceutical compositions prepared therefrom
12/21/2000WO2000076506A1 Pharmaceutical formulations and methods comprising intranasal morphine
12/21/2000WO2000076496A1 Tumor tissue accumulation enhancers for drugs
12/21/2000WO2000076491A1 Utilization of a highly fluorinated oligomeric alkan in ophthalmology
12/21/2000WO2000076489A2 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits
12/21/2000WO2000076486A1 Silver-containing, sol-gel derived bioglass compositions
12/21/2000WO2000076485A1 Moisture-sensitive preparation of percutaneous absorption type
12/21/2000WO2000076484A1 Pharmaceutical preparation with delayed release of an active substance
12/21/2000WO2000076483A1 Process for preparing biodegradable microspheres containing physiologically active agents
12/21/2000WO2000076482A1 Novel formulations comprising lipid-regulating agents
12/21/2000WO2000076481A1 Mesalazine controlled release oral pharmaceutical compositions
12/21/2000WO2000076480A2 Pharmaceutical materials and methods for their preparation and use
12/21/2000WO2000076479A1 Taste masked compositions
12/21/2000WO2000076478A1 Controlled release and taste masking oral pharmaceutical compositions
12/21/2000WO2000076477A1 Methods and compositions for treating breakthrough pain
12/21/2000WO2000076476A1 Adjuvant-containing polymerized liposomes for oral, mucosal or intranasal vaccination
12/21/2000WO2000076475A1 Prophylactic, therapeutic and industrial antioxidant compositions enhanced with stabilized atomic hydrogen/free electrons and methods to prepare and use such compositions
12/21/2000WO2000076474A1 Acidic buffered nasal spray
12/21/2000WO2000076452A2 Pharmaceutical compositions with wound healing or anti-complementary activity comprising a dextran derivative
12/21/2000WO2000076437A1 Soluble keratin peptide
12/21/2000WO2000076315A1 Transdermally delivered aspirin
12/21/2000WO2000076314A1 Compositions and methods comprising morphine gluconate
12/21/2000WO2000054747A3 Method for treating dry eye
12/21/2000WO2000052049A3 A method for purifying human growth hormone
12/21/2000WO2000050062A3 Methods and compositions for altering mucus secretion
12/21/2000WO2000050047A3 Composition for the treatment of psoriasis
12/21/2000WO2000050014A3 Phenytoin sodium pharmaceutical compositions
12/21/2000WO2000050008A3 Antibody fragment-targeted immunoliposomes for systemic gene delivery
12/21/2000WO2000048642A3 Biocompatible material with a novel functionality
12/21/2000WO2000045791A3 Method for controlling liposome size
12/21/2000WO2000045167A3 Non-invasive method for detecting target rna
12/21/2000WO2000044367A3 A pharmaceutical composition of complex carbohydrates and essential oils and methods of using the same
12/21/2000WO2000044366A3 Therapeutic compositions containing glutathione analogs
12/21/2000WO2000035418A3 Chewable drug delivery system
12/21/2000WO2000028972A3 Nanocapsules and method of production thereof
12/21/2000WO2000007577A8 Phosphatidylcholine as a medicament for the protection of mucosa
12/21/2000WO1999059572A8 Gamma-aminobutyric acid derivatives containing, solid compositions and process for preparing the same
12/21/2000WO1998006436A3 Inhibiting undesirable taste in oral compositions
12/21/2000DE19945203A1 Lipid particles based on matrix comprising solid and liquid lipid, useful in diagnostics and for controlled release of active agents, especially pharmaceuticals
12/21/2000DE19928312A1 Arzneimittelzubereitung mit verzögerter Wirkstoffabgabe Pharmaceutical preparation with delayed release of active ingredient
12/21/2000DE19928112A1 Balanced mixtures of Guerbet alcohols, including new 2-hexyl-1-tetradecanol, useful as oil components of cosmetic and pharmaceutical compositions
12/21/2000DE19927689A1 Oral dosage formulation containing tramadol and diclofenac, useful for treating pain, contains the active ingredients in separate subunits
12/21/2000DE19927688A1 Multi-layered tablet containing tramadole and diclofenac, useful for treating pain, has separating layer between active ingredient layers
12/21/2000DE10020688A1 System zur Medikamenten-Bolus Abgabe System for drug bolus delivery
12/21/2000CA2379048A1 Pharmaceutical compositions with wound healing or anti-complementary activity comprising a dextran derivative
12/21/2000CA2377232A1 Prophylactic, therapeutic and industrial antioxidant compositions enhanced with stabilized atomic hydrogen/free electrons and methods to prepare and use such compositions
12/21/2000CA2376921A1 Nasal delivery of apomorphine
1 ... 2429 2430 2431 2432 2433 2434 2435 2436 2437 2438 2439 2440 2441 2442 2443 2444 2445 2446 2447 2448 2449 ... 2991